George Donato

Chief Operating Officer presso OYSR POIN

Health Technology

Consumer Services

Profilo

George Donato is currently working as Senior Vice President-Operations & CMC at Oyster Point Pharma, Inc. He previously worked as Senior Vice President-Operations at Iroko Pharmaceuticals, Inc. He completed his undergraduate degree and MBA from Widener University.

Posizioni attive di George Donato

Società	Posizione	Inizio
OYSR POIN	Chief Operating Officer	-

Tutte le posizioni attive di George Donato

Precedenti posizioni note di George Donato

Società	Posizione	Fine
Iroko Pharmaceuticals, Inc. Iroko Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Iroko Pharmaceuticals, Inc. develops and distributes pharmaceutical products. Its products include Indocin and Aldomet. The company was founded on January 18, 2007 and is headquartered in Philadelphia, PA.	Chief Operating Officer	-

Vedi nel dettaglio l'esperienza di George Donato

Formazione di George Donato

Widener University

Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di George Donato

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Iroko Pharmaceuticals, Inc. Iroko Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Iroko Pharmaceuticals, Inc. develops and distributes pharmaceutical products. Its products include Indocin and Aldomet. The company was founded on January 18, 2007 and is headquartered in Philadelphia, PA.	Health Technology
Oyster Point Pharma, Inc. Oyster Point Pharma, Inc. Pharmaceuticals: MajorHealth Technology Oyster Point Pharma, Inc. engages in the development and commercialization of pharmaceutical therapies to treat ocular surface diseases. Its product candidate, OC-01, is a nicotinic acetylcholine receptor agonist, which is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. The company was founded by Michael and is Ackermann in June 30, 2015 headquartered in Princeton, NJ.	Health Technology